IL-10 Dysregulation in acute mountain sickness revealed by transcriptome analysis

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Liu, Bao ^a,b   Chen, Jian ^a,b   Zhang, Long ^c   Gao, Yixing ^a,b   Cui, Jianhua ^d   Zhang, Erlong ^a,b   Xu, Gang ^a,b   Liang, Yan ^c   Liang, Yu ^c   Wang, Jian ^c   Gao, Yuqi ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Third Military Medical College   (China)

^c BGI SHENZHEN   (China)

^d The 18th Hospital of PLA   (China)

Author keywords

Acute mountain sickness; Immune response; Inflammatory response; Interleukin 10; RNA seq

Indexed keywords

INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 2; TRANSCRIPTOME;

ADULT; ALTITUDE DISEASE; APOPTOSIS; ARTICLE; AWARENESS; BLOOD PRESSURE MONITORING; CLUSTER ANALYSIS; CORRELATION ANALYSIS; DISEASE SEVERITY ASSESSMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL CONNECTIVITY; GENE EXPRESSION; GENE ONTOLOGY; HEART RATE; HUMAN; HUMAN EXPERIMENT; IMMUNE DYSREGULATION; IMMUNE RESPONSE; INFLAMMATION; LOUISE SCORING SYSTEM; MALE; MIDDLE AGED; NORMAL HUMAN; OXYGEN SATURATION; QUESTIONNAIRE; RECEPTOR DOWN REGULATION; RISK FACTOR; SCORING SYSTEM; SEQUENCE ANALYSIS; VALIDATION STUDY; YOUNG ADULT;

EID: 85020032575     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00628     Document Type: Article

References (45)

1. Hackett PH, Roach RC. High-altitude illness. N Engl J Med (2001) 345:107-14. doi: 10.1056/NEJM200107123450206
2. Bartsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. N Engl J Med (2013) 368:2294-302. doi:10.1056/NEJMcp1214870
3. MacInnis MJ, Carter EA, Freeman MG, Pandit BP, Siwakoti A, Subedi A, et al. A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m). PLoS One (2013) 8:e75644. doi:10.1371/journal.pone.0075644
4. Salazar H, Swanson J, Mozo K, White AC Jr, Cabada MM. Acute mountain sickness impact among travelers to Cusco, Peru. J Travel Med (2012) 19:220-5. doi:10.1111/j.1708-8305.2012.00606.x
5. McDevitt M, McIntosh SE, Rodway G, Peelay J, Adams DL, Kayser B. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up. Wilderness Environ Med (2014) 25:152-9. doi:10.1016/j.wem.2013.12.027
6. Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol (2004) 5:410-9. doi:10.1089/ham.2004.5.410
7. Waeber B, Kayser B, Dumont L, Lysakowski C, Tramer MR, Elia N. Impact of study design on reported incidences of acute mountain sickness: a systematic review. High Alt Med Biol (2015) 16:204-15. doi:10.1089/ham.2015.0022
8. Wilson MH, Davagnanam I, Holland G, Dattani RS, Tamm A, Hirani SP, et al. Cerebral venous system and anatomical predisposition to high-altitude headache. Ann Neurol (2013) 73:381-9. doi:10.1002/ana.23796
9. Loeppky JA, Icenogle MV, Maes D, Riboni K, Hinghofer-Szalkay H, Roach RC. Early fluid retention and severe acute mountain sickness. J Appl Physiol (2005) 98:591-7. doi:10.1152/japplphysiol.00527.2004
10. Lopez JI, Holdridge A, Mendizabal JE. Altitude headache. Curr Pain Headache Rep (2013) 17:383. doi:10.1007/s11916-013-0383-2
11. DiPasquale DM, Muza SR, Gunn AM, Li Z, Zhang Q, Harris NS, et al. Evidence for cerebral edema, cerebral perfusion, and intracranial pressure elevations in acute mountain sickness. Brain Behav (2016) 6:e00437. doi:10.1002/brb3.437
12. Van Osta A, Moraine JJ, Melot C, Mairbaurl H, Maggiorini M, Naeije R. Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke (2005) 36:557-60. doi:10.1161/01.STR.0000155735.85888.13
13. Lu H, Wang R, Xiong J, Xie H, Kayser B, Jia ZP. In search for better pharmacological prophylaxis for acute mountain sickness: looking in other directions. Acta Physiol (2015) 214:51-62. doi:10.1111/apha.12490
14. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med (2006) 147:126-32. doi:10.1016/j.lab.2005.10.005
15. Kohane IS, Valtchinov VI. Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome. Bioinformatics (2012) 28:538-45. doi:10.1093/bioinformatics/btr713
16. Roach RC, Bärtsch P, Oelz O, Hackett PH. Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, editors. Hypoxia and Molecular Medicine. Burlington, VT: Charles S. Houston (1993). p. 272-4.
17. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 25:1105-11. doi:10.1093/bioinformatics/btp120
18. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 10:R25. doi:10.1186/gb-2009-10-3-r25
19. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods (2008) 5:621-8. doi:10.1038/nmeth.1226
20. Hu J, Xu J. Density based pruning for identification of differentially expressed genes from microarray data. BMC Genomics (2010) 11(Suppl 2):S3. doi:10.1186/1471-2164-11-S2-S3
21. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 4:44-57. doi:10.1038/nprot.2008.211
22. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol (1999) 87:1734-40.
23. Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer (2011) 2:1117-33. doi:10.1177/1947601911423654
24. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol (2013) 13:349-61. doi:10.1038/nri3423
25. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical organization of modularity in metabolic networks. Science (2002) 297:1551-5. doi:10.1126/science.1073374
26. Hu Z, Mellor J, Wu J, Yamada T, Holloway D, Delisi C. VisANT: data-integrating visual framework for biological networks and modules. Nucleic Acids Res (2005) 33:W352-7. doi:10.1093/nar/gki431
27. Tang E, Chen Y, Luo Y. Dexamethasone for the prevention of acute mountain sickness: systematic review and meta-analysis. Int J Cardiol (2014) 173:133-8. doi:10.1016/j.ijcard.2014.03.019
28. Agarwal SK, Marshall GD Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res (2001) 21:147-55. doi:10.1089/107999001750133159
29. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med (2002) 195:603-16. doi:10.1084/jem.20011629
30. Boos CJ, Woods DR, Varias A, Biscocho S, Heseltine P, Mellor AJ. High altitude and acute mountain sickness and changes in circulating endothelin-1, interleukin-6, and interleukin-17a. High Alt Med Biol (2016) 17:25-31. doi:10.1089/ham.2015.0098
31. Julian CG, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol (2011) 111:392-9. doi:10.1152/japplphysiol.00391.2011
32. Song TT, Bi YH, Gao YQ, Huang R, Hao K, Xu G, et al. Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia. J Neuroinflammation (2016) 13:63. doi:10.1186/s12974-016-0528-4
33. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 10:170-81. doi:10.1038/nri2711
34. Hoffmann MS, Singh P, Wolk R, Narkiewicz K, Somers VK. Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. Atherosclerosis (2013) 231:378-83. doi:10.1016/j.atherosclerosis.2013.09.033
35. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 8:362-71. doi:10.1038/nri2297
36. Muhie S, Hammamieh R, Cummings C, Yang D, Jett M. Transcriptome characterization of immune suppression from battlefield-like stress. Genes Immun (2013) 14:19-34. doi:10.1038/gene.2012.49
37. Meehan RT. Immune suppression at high altitude. Ann Emerg Med (1987) 16:974-9. doi:10.1016/S0196-0644(87)80743-6
38. Mishra KP, Ganju L. Influence of high altitude exposure on the immune system: a review. Immunol Invest (2010) 39:219-34. doi:10.3109/08820131003681144
39. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med (2011) 364:656-65. doi:10.1056/NEJMra0910283
40. Dace DS, Khan AA, Kelly J, Apte RS. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One (2008) 3:e3381. doi:10.1371/journal.pone.0003381
41. Lai Z, Kalkunte S, Sharma S. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension (2011) 57:505-14. doi:10.1161/HYPERTENSIONAHA.110.163329
42. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol (2011) 29:71-109. doi:10.1146/annurev-immunol-031210-101312
43. O'Boyle G, Brain JG, Kirby JA, Ali S. Chemokine-mediated inflammation: identification of a possible regulatory role for CCR2. Mol Immunol (2007) 44:1944-53. doi:10.1016/j.molimm.2006.09.033
44. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol (2001) 204:3161-70.
45. Schoonman GG, Sandor PS, Nirkko AC, Lange T, Jaermann T, Dydak U, et al. Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab (2008) 28:198-206. doi:10.1038/sj.jcbfm.9600513